Financial statements Aronpharma
Balance sheet of Aronpharma
Company age:
Age:
7 y. 2 d.
Share capital:
Share capital:
5 100 PLN
Balance sheet data of ARONPHARMA
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 141 210,87 | 919 934,98 | 5 269 134,65 | 3 948 747,68 | 5 324 028,45 |
| A. Fixed assets | 7 610,00 | 101 955,22 | 407 452,87 | 230 866,25 | 61 250,87 |
| B. Current assets | 133 600,87 | 817 979,76 | 4 861 681,78 | 3 717 881,43 | 5 262 777,58 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - |
| Total liabilities | 141 210,87 | 919 934,98 | 5 269 134,65 | 3 948 747,68 | 5 324 028,45 |
| A. Equity | -139 502,97 | -406 839,58 | 486 822,42 | -55 814,51 | -284 805,27 |
| B. Liabilities and provisions for liabilities | 280 713,84 | 1 326 774,56 | 4 782 312,23 | 4 004 562,19 | 5 608 833,72 |
| I. Long-term liabilities | - | - | - | 0,00 | 0,00 |
| II. Short-term liabilities | - | - | - | 3 595 562,19 | 4 449 281,74 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.